Wegovy approved for cutting cardiovascular disease risk The TGA has approved semaglutide (sold as Wegovy) as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in overweight and obese adults.
Who is most likely to turn to ChatGPT for health information? New Australian research has uncovered how many patients are using the AI tool for clinical advice and just what questions they are asking.
GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
Aboriginal-led study sees 30% achieve diabetes remission A first-of-its-kind study in Australia has highlighted the importance of community-led initiatives in diabetes management.
Study urges tailored use of MHT Shared decision-making and an individualised approach are key when it comes to MHT, but there is an ‘urgent need’ for more research.
Pregnancy status soon mandated for AIR reporting From 1 March, new laws mean vaccination providers must record a patient’s pregnancy details at the time of their vaccine administration.
ADHD med shortages ‘a merry-go-round you just can’t predict’ The new school year has coincided with another series of shortages, forcing patients and prescribers to rethink their options.
‘An important milestone’: New MS guidelines published The first consensus statement for multiple sclerosis in Australia and New Zealand includes 80 recommendations for treating the disease.
What does the $573m women’s health package mean for GPs? Labor’s plan, matched by the Coalition, includes new PBS listings for contraceptive pills and MHT, new rebates, funded training, and bolstered Medicare payments for IUD insertions.
New cervical screening guidelines broaden self-collect options The incoming guidelines bring simplification ‘without compromising quality and safety’ and increase the role of self-collection.